Dysregulation of circulating CD4+CXCR5+ T cells in type 2 diabetes mellitus

APMIS

Volumn 123, Issue 2, 2015, Pages 146-151

  Wang, Qijin ^a   Zhai, Xiao ^a   Chen, Xiao ^a   Lu, Jiancan ^a   Zhang, Yaping ^a   Huang, Qin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD4+CXCR5+ T cells; Circulating; Obesity; Type 2 diabetes mellitus

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CCR6 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN; CXCR5 PROTEIN, HUMAN;

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETIC OBESITY; DIABETIC PATIENT; DIABETOGENESIS; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; TH17 CELL; AGED; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; OBESITY;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD4; B-LYMPHOCYTES; BODY MASS INDEX; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OBESITY; RECEPTORS, CCR6; RECEPTORS, CXCR3; RECEPTORS, CXCR5; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84921448541     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12330     Document Type: Article

References (20)

1. Meerza D, Naseem I, Ahmed J. Pharmacology of signaling pathways: in type 2 diabetes. Diabetes Metab Syndr 2013;7:180-5.
2. Sun X, Yu W, Hu C. Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application. Biomed Res Int 2014;2014:926713.
3. Winer DA, Winer S, Chng MH, Shen L, Engleman EG. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci 2014;71:1033-43.
4. Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J Immunol 2014;192:623-9.
5. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013;17:851-9.
6. Stolarczyk E, Lord GM, Howard JK. The immune cell transcription factor T-bet: a novel metabolic regulator. Adipocyte 2014;3:58-62.
7. Vinuesa CG, Tangye SG, Moser B, Mackay CR. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 2005;5:853-65.
8. Fazilleau N, Eisenbraun MD, Malherbe L, Ebright JN, Pogue-Caley RR, McHeyzer-Williams LJ, et al. Lymphoid reservoirs of antigen-specific memory T helper cells. Nat Immunol 2007;8:753-61.
9. Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005;435:452-8.
10. Yang X, Yang J, Chu Y, Xue Y, Xuan D, Zheng S, et al. T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus. PLoS ONE 2014;9:e88441.
11. Maseda D, Bonami RH, Crofford LJ. Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis. Expert Rev Clin Immunol 2014;10:747-62.
12. Wang Y, Yang Y, Luo Y, Yin Y, Wang Q, Li Y, et al. Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis. Clin Immunol 2013;149:46-54.
13. Garabatos N, Alvarez R, Carrillo J, Carrascal J, Izquierdo C, Chapman HD, et al. In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis. J Immunol 2014;192:3080-90.
14. Li XY, Wu ZB, Ding J, Zheng ZH, Li XY, Chen LN, et al. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren's syndrome. Biochem Biophys Res Commun 2012;422:238-44.
15. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011;34:108-21.
16. Shi W, Li X, Cha Z, Sun S, Wang L, Jiao S, et al. Dysregulation of circulating follicular helper T cells in nonsmall cell lung cancer. DNA Cell Biol 2014;33:355-60.
17. Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014;20:633-41.
18. Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease. Immunol Rev 2014;259:259-72.
19. Cha Z, Zang Y, Guo H, Rechlic JR, Olasnova LM, Gu H, et al. Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia. Tumour Biol 2013;34:3579-85.
20. Xiao H, Luo G, Son H, Zhou Y, Zheng W. Upregulation of peripheral CD4+CXCR5+ T cells in osteosarcoma. Tumour Biol 2014;35:5273-9.